12 October 2022 false Taxfiler 2023.10 14414289business:PrivateLimitedCompanyLtd2022-10-122023-10-31 144142892022-10-11 144142892022-10-122023-10-31 14414289business:AuditExemptWithAccountantsReport2022-10-122023-10-31 14414289business:FilletedAccounts2022-10-122023-10-31 144142892023-10-31 14414289business:Director12022-10-122023-10-31 14414289business:Director22022-10-122023-10-31 14414289business:RegisteredOffice2022-10-122023-10-31 14414289core:WithinOneYear2023-10-31 14414289core:ShareCapitalcore:PreviouslyStatedAmount2023-10-31 14414289core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-10-31 14414289core:PreviouslyStatedAmount2023-10-31 14414289business:SmallEntities2022-10-122023-10-31 14414289countries:EnglandWales2022-10-122023-10-31 14414289core:ComputerEquipment2022-10-122023-10-31 14414289core:ComputerEquipment2022-10-11 14414289core:ComputerEquipment2023-10-31 iso4217:GBP xbrli:pure
Company Registration No. 14414289 (England and Wales)
GX Pharma Limited Unaudited accounts for the period from 12 October 2022 to 31 October 2023
GX Pharma Limited Unaudited accounts Contents
Page
- 2 -
GX Pharma Limited Company Information for the period from 12 October 2022 to 31 October 2023
Directors
Stephen Jackson Pauline Evans
Company Number
14414289 (England and Wales)
Registered Office
3a Blue Sky Way Monkton Business Park South Hebburn Tyne and Wear NE31 2EQ England
Accountants
Abacus Accounting (NE) Limited 3a Blue Sky Way Monkton Business Park South Hebburn Tyne and Wear NE31 2EQ
- 3 -
GX Pharma Limited Statement of financial position as at 31 October 2023
2023 
Notes
£ 
Fixed assets
Tangible assets
786 
Current assets
Cash at bank and in hand
69,484 
Creditors: amounts falling due within one year
(19,915)
Net current assets
49,569 
Net assets
50,355 
Capital and reserves
Called up share capital
100 
Profit and loss account
50,255 
Shareholders' funds
50,355 
For the period ending 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 16 November 2023 and were signed on its behalf by
Stephen Jackson Director Company Registration No. 14414289
- 4 -
GX Pharma Limited Notes to the Accounts for the period from 12 October 2022 to 31 October 2023
1
Statutory information
GX Pharma Limited is a private company, limited by shares, registered in England and Wales, registration number 14414289. The registered office is 3a Blue Sky Way, Monkton Business Park South, Hebburn, Tyne and Wear, NE31 2EQ, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
10% straight line
4
Tangible fixed assets
Computer equipment 
£ 
Cost or valuation
At cost 
At 12 October 2022
- 
Additions
873 
At 31 October 2023
873 
Depreciation
Charge for the period
87 
At 31 October 2023
87 
Net book value
At 31 October 2023
786 
- 5 -
GX Pharma Limited Notes to the Accounts for the period from 12 October 2022 to 31 October 2023
5
Creditors: amounts falling due within one year
2023 
£ 
VAT
(344)
Trade creditors
1,200 
Taxes and social security
12,029 
Loans from directors
7,030 
19,915 
6
Average number of employees
During the period the average number of employees was 2.
- 6 -